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ABSTRACT 
Objective: Diabetes mellitus increased inflammation through stimulation of arachidonic acid liberation from the cell membranes which is 
transformed into actively cellular mediators such as thromboxanes, prostaglandins, and leukotrienes. So, this study aimed to investigate the effect of 
flaxseed oil as a source of omega 3 fatty acids on releasing of arachidonic acid from erythrocyte membrane and also on possible reduction of 
hyperhomocysteinemia during experimental diabetes.  
Methods: Forty male albino rats were used in this study and divided into four groups: control, diabetic, flaxseed oil and treated groups. After the 
experimental period, blood samples were collected to estimate different biochemical parameters in plasma and in the erythrocyte membrane.  
Results: The data showed the elevation of membrane arachidonic acid along with the elevation of inflammatory and oxidative stress markers in the 
diabetic group while flaxseed oil supplementation significantly decreased these levels. 
Conclusion: We concluded that flaxseed oil is a promising supplement during diabetes mellitus due to its powerful effect in reducing arachidonic 
acid release and inhibition of hyperhomocysteinemia.  
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INTRODUCTION  
During diabetes, hyperglycemia causes elevation of free radicals 
production such as reactive oxygen species (ROS) for all tissues from 
protein glycosylation and glucose auto-oxidation. The high levels of 
free radicals and decline of antioxidant systems can lead to the 
damage of enzymes and cellular organelles, increased lipid 
peroxidation, and development of diabetes mellitus [1]. 
In addition, Diabetes mellitus increased inflammation through 
stimulation of arachidonic acid releasing from the cell membranes 
which is transformed into actively cellular mediators such as 
thromboxanes, prostaglandins, and leukotrienes [2] in addition to 
elevation of homocysteine (Hcy) level. Hcy may be a good biomarker 
for increased risk of diabetes complications. Since retinopathy, 
nephropathy, neuropathy and cardiovascular disease have all been 
linked to higher Hcy levels [3]. 
Hyperhomocysteinemia has been documented in patients with 
vascular disorders; also increased homocysteine level is a well-
defined risk factor of thrombosis and atherosclerosis [4]. Several 
studies indicated that omega-3 fatty acids can reduce inflammatory 
process activity [5].  
Since natural products have played an important role throughout 
the world in both treatment and prevention of human from several 
diseases and flaxseed oil is documented as the best plant that 
contain high amount of polyunsaturated fatty acids especially 
omega-3 [6], so this study aimed to investigate the effect of flaxseed 
oil as a source of omega 3 fatty acids on releasing of arachidonic acid 
from erythrocyte membrane and also on possible reduction of 
hyperhomocysteinemia during experimental diabetes. 
MATERIALS AND METHODS  
Materials  
The following chemicals were purchased from Sigma Chemicals Co. 
(Munih,Germany). 
- Streptozotosin (STZ) (CAS Number: 18883-66-4). 
- Homocysteine (Hcy) (CAS Number: 454-29-5). 
- α–linolenic acid (ALA) (CAS Number 506-26-3). 
- Arachidonic acid (AA) (CAS Number: 506-32-1). 
Plant  
Flaxseed oil was purchased from the local market. 
Experimental animals  
Forty male albino rats (180±10 g) were used in this study. Rats were 
obtained from the animal house of the National Research Centre 
(NRC) (Cairo, Egypt) and they were housed in stainless steel cages 
under controlled conditions. The temperature was 23-26 °C and the 
light/dark cycle was 12/12 h. The animals had free access to water 
and a standard rodent chow diet. All animals received human care in 
compliance with guidelines of the Ethical Committee of National 
Research Centre (NRC), Egypt and followed the National Institutes of 
Health Guide Recommendations Care and Use of Laboratory 
Animals. The number of ethical committee permission is (10/219). 
Methods  
Induction of diabetes mellitus  
STZ was dissolved in sodium citrate (50 mM and PH was adjusted to 
4.5) solution containing NaCl (150 mM). The solution (6.0 mg/0.5 
ml/100g body weight) was subcutaneously injected into rats of 
group 3 and 4; after 3 d, fasting blood sugar was estimated to 
confirm the development of diabetes mellitus [7].  
Experimental design  
Forty male albino rats were used in this study and divided into four 
groups as follow:  
Group I (control group): healthy rats received 1.2 ml corn oil. 
Group II (flaxseed oil group): healthy rats received 1.2 ml flaxseed 
oil/kg b.w./day orally. 
Group III (diabetic group): diabetic rats received 1.2 ml corn oil. 
Group IV (treated group): diabetic rats received 1.2 ml flaxseed 
oil/kg b.w./day orally for 8 w [6].  
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After the experimental period, animals were kept fasting for 12 h 
before blood sampling, blood was withdrawn from the retro-orbital 
venous plexus of the eye using capillary tubes and collected in 
heparinized tubes for biochemical parameters estimations. Blood 
was centrifuged at 2000 rpm for 10 min using cooling centrifuge. 
Plasma was separated; fasting blood glucose was estimated 
immediately using enzymatic colorimetric method. Centronic, 
Germany [8]. The rest of plasma was frozen. Packed RBCs were used 
for isolation of erythrocyte membrane. 
The method used for erythrocyte ghost preparation was based on 
the hemolysis of RBCs in hypotonic solution for removal of 
hemoglobin [9]. 
Reduced glutathione (GSH) and malondialdehyde (MDA) were 
estimated in erythrocyte membrane according to the methods 
described before [10, 11] respectively. 
Plasma insulin level was estimated by ELISA [12] using Bio Soure 
INS-EASIA Kit.  
Erythrocyte membrane lipids were extracted with chloroform: methanol 
method modified from the method described previously [13]. 
Estimation of arachidonic and α–linolenic acids by HPLC 
Erythrocyte membrane fatty acids were estimated by HPLC, Agilent 
technologies 1100 series, equipped with a quaternary pump (Quat. 
pump, G131A model). 
Sample preparation  
Erythrocyte membrane was homogenized in acetic acid (2 %): ethyl 
ether mixture (2:1) v/v. The solution was centrifuged at 3000 rpm, 
the organic phase was evaporated to dryness. The extract was then 
dissolved in 400 μl acetonitrile and filtered through hydrophilic 
PVDF 0.45 µ m.  
HPLC condition  
This method was carried out by reversed phase HPLC column (260 X 4.6, 
particle size 5μl) according to the method described previously [6], 
mobile phase was acetonitrile/water mixture (70/30) v/v by isocratic 
elution with flow rate 1 ml/min and UV detector was set at 200 nm. 
Serial dilutions of standards were injected onto HPLC and their peak 
areas were determined. A linear standard curve was constructed by 
plotting peak areas versus the corresponding concentrations. The 
concentration in samples was obtained from the standard curve. 
Determination of plasma homocysteine (hcy) 
Homocysteine was estimated by high performance liquid 
chromatography (HPLC) according to the method described 
previously [14]. 
Sample extraction 
200 μl plasma were treated with 16 μl TCA, mixed well and 
incubated in ice for 30 min to precipitate protein. After 
centrifugation for 20 min at 4000 rpm at 4 °C, supernatants were 
filtered through hydrophilic PVDF 0.45 µ m. 
HPLC condition 
30 µl from the solution were injected in HPLC; separation was 
achieved on reversed phase column (C18, 25, 0.46 cm i.d. 5 µ m). The 
mobile phase consisted of 40 mmol/l sodium phosphate monobasic 
monohydrate; 8 mmol/l heptane sulfonic acid and 18% (v/v) 
methanol adjusted to pH 3.1 by addition of phosphoric acid and 
filtered through a 0.45-μm membrane filter and was delivered at a 
flow rate of 1 ml/min at 40 °C. UV detector was performed at 260 
nm. Serial dilutions of standards were injected, and their peak areas 
were determined. A linear standard curve was constructed by 
plotting peak areas versus the corresponding concentrations. The 
concentrations in samples were obtained from the standard curve. 
Statistical analysis  
Results were expressed as mean±standard error. Data were 
analyzed by independent sample t test (SPSS) version 15 followed 
by (LSD) test to compare significance between groups. Difference 
was considered significant when P value<0.05. 
RESULTS AND DISCUSSION 
During diabetes, hyperglycemia causes elevation of reactive oxygen 
species (ROS) and increased inflammation through the stimulation 
of arachidonic acid releasing from the cell membrane. In this study, 
STZ-induced experimental diabetes significantly decreased 
erythrocyte membrane antioxidant enzyme (SOD) concomitant with 
an elevation of erythrocyte membrane MDA (table 2) in addition to 
the increase of inflammatory markers that increased through the 
releasing of arachidonic acid from the cell membrane. Thus in this 
study, homocysteine, IL-1 α, and TNF-α were increased (table3) 
concomitant with an elevation of erythrocyte membrane arachidonic 
acid and reduction of erythrocyte membrane α-Linolenic acid in 
diabetic group (table 4). 
 
Table 1: Fasting blood glucose and insulin levels in different studied groups 
Groups Glucose (mg/dl) Insulin (μIU/ml) 
Control group 77.67±1.1 11.3±0.9 
Flaxseed oil group 78.49±1.7 11.8±1.4 ♦ 
Diabetic group 252.66±2.2 8.6±1.3 ♥ 
Treated group 172.70±1.6 9.9±1.8 ♥♦ 
Results are expressed as mean±SE, n=10, ♥ significant difference compared to control group, ♦
 
 Significant difference compared to diabetic group.  
Table 2: Erythrocyte membrane oxidative stress parameters in different studied groups 
 Groups MDA (nmol/ml RBCs) SOD (U/ml RBCs) 
Control group 0.89±0.18 466.5±2.3 






2.53±0.19 382.5±1.9♥,♦ ♥,♦ 
Results are expressed as mean±SE, n=10, ♥ significant difference compared to control group, ♦
 
 Significant difference compared to diabetic group.  
Table 3: Inflammatory markers in different studied groups 
Groups Homocysteine μ mol/l IL-1α Pg/ml TNF-α Pg/ml 
Control group 4.6±1.27 19±1.1 40.6±1.7 
Flaxseed oil group 3.8±0.99 20.4±1.4♦ 41.2±1.6♦ 
Diabetic group 
♦ 
22.7±1.20 42±1.4♥ 66.9±2.0♥ 
Treated group 
♥ 
12.5±1.32 27±1.6♥,♦ 47.7±1.8♦ ♦ 
Results are expressed as mean±SE, n=10, ♥ significant difference compared to control group, ♦ Significant difference compared to diabetic group.  
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Arguably; the most important polyunsaturated fatty acids in the cell 
membrane is the omega-6 family member AA. When the cells are 
activated by internal or external stimuli, arachidonic acid is 
immediately released from cell membranes and transformed into 
cellular mediators such as thromboxanes, prostaglandins and 
leukotrienes [15] hydroxy fatty acids, and lipoxins [16]. These 
mediators possess a range of activities, including activation of 
leukocytes and platelets, regulation of gastric secretions, induction 
of bronchoconstriction and signaling of pain in nerve cells and 
inflammation [17]. 
So, arachidonic acid metabolism is considered the target of non 
steroidal anti-inflammatory drugs (e. g., acetylsalicylic acid and 
ibuprofen), cyclooxygenase-2 (COX-2) inhibitors (e. g., rofecoxib and 
celecoxib) and leukotriene antagonists (e. g., montelukast and 
zafirlukast [18]. 
 
Table 4: Erythrocyte membrane α-Linolenic and arachidonic acids in different studied groups 
 Groups α-Linolenic acid (mg/ml RBCs)  Arachidonic acid (mg/ml RBCs)  
Control group 0.82±0.03 0.05±0.01 






0.81±0.31 ♦ 0.07±0.03  ♦  
Results are expressed as mean±SE, n=10, ♥ significant difference compared to control group, ♦
 
Diet-induced changes in the polyunsaturated fatty acid composition 
of cell membranes have an important role in the cell’s functions and 
activities, partially because these fatty acids represent a reservoir of 
molecules that perform important signaling or communication roles 
within and between cells.  
In this study, supplementation of flaxseed oil to diabetic rats 
significantly decreased lipid peroxidation (MDA) in addition to 
antioxidant enzyme (SOD) elevation (table 2), Also decreased 
inflammatory markers (table 3). 
Administration of flaxseed oil in this study as a source of omega-3 
fatty acids (mainly α-linolenic acid) enhanced omega 3 fatty acids to 
compete with omega-6 family for incorporation into cell membranes 
[19, 20] resulting in a reduction of arachidonic acid liberation from 
the cell membrane as was found in our study, thus flaxseed oil 
supplementation significantly decreased arachidonic acid level and 
increased α-Linolenic acid in the cell membrane (table 4).  
The reduction of arachidonic acid lead to a reduction of reactive 
oxygen species (ROS) and increasing SOD level in addition to the 
reduction of inflammatory markers. In the same line, the current 
data indicated a reduction of inflammatory markers in flaxseed oil 
treated group (table 2, 3) especially Hcy, the risk factor of diabetes 
complication. 
CONCLUSION 
In conclusion, these data proofed the potential effect of flaxseed oil 
as a plant source of omega 3 fatty acids in reducing inflammation as 
well as oxidative stress. The anti-inflammatory and antioxidant 
properties of flaxseed oil are related to its incorporation into the cell 
membranes and reducing arachidonic acid and homocysteine levels. 
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